RBP-J regulates homeostasis and function of circulating Ly6Clo monocytes

Notch-RBP-J signaling plays an essential role in the maintenance of myeloid homeostasis. However, its role in monocyte cell fate decisions is not fully understood. Here, we showed that conditional deletion of transcription factor RBP-J in myeloid cells resulted in marked accumulation of blood Ly6C l...

Full description

Saved in:
Bibliographic Details
Published ineLife Vol. 12
Main Authors Kou, Tiantian, Kang, Lan, Zhang, Bin, Li, Jiaqi, Zhao, Baohong, Zeng, Wenwen, Hu, Xiaoyu
Format Journal Article
LanguageEnglish
Published Cambridge eLife Sciences Publications Ltd 26.02.2024
Subjects
Online AccessGet full text
ISSN2050-084X
2050-084X
DOI10.7554/eLife.88135

Cover

More Information
Summary:Notch-RBP-J signaling plays an essential role in the maintenance of myeloid homeostasis. However, its role in monocyte cell fate decisions is not fully understood. Here, we showed that conditional deletion of transcription factor RBP-J in myeloid cells resulted in marked accumulation of blood Ly6C lo monocytes that highly expressed chemokine receptor CCR2. Bone marrow transplantation and parabiosis experiments revealed a cell-intrinsic requirement of RBP-J for controlling blood Ly6C lo CCR2 hi monocytes. RBP-J-deficient Ly6C lo monocytes exhibited enhanced capacity competing with wildtype counterparts in blood circulation. In accordance with alterations of circulating monocytes, RBP-J deficiency led to markedly increased population of lung tissues with Ly6C lo monocytes and CD16.2 + interstitial macrophages. Furthermore, RBP-J deficiency-associated phenotypes could be genetically corrected by further deleting Ccr2 in myeloid cells. These results demonstrate that RBP-J functions as a crucial regulator of blood Ly6C lo monocytes and thus derived lung-resident myeloid populations, at least in part through regulation of CCR2.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2050-084X
2050-084X
DOI:10.7554/eLife.88135